RCUS

Bullish

Arcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $36.73, Implies 58% Upside

Arcus Biosciences, Inc.'s average 12-month price target has been increased to $36.73 from $35.75, representing a potential upside of approximately 58%...

TradingView 2 weeks ago 0

Neutral

RCUS Initiated Coverage by LifeSci Capital -- Rating Set to Outp

LifeSci Capital has initiated coverage on Arcus Biosciences (RCUS) with an Outperform rating and a price target of $46.00, signaling a positive outloo...

GuruFocus 2 weeks ago 0